CHM chimeric therapeutics limited

Ann: Appendix 4E and Preliminary Final Report, page-15

  1. 280 Posts.
    lightbulb Created with Sketch. 66
    You will see the details in the final annual report as shown by last years report below:
    https://hotcopper.com.au/data/attachments/4640/4640734-9b1a062abf47f704e6f7ea2ea322c109.jpg

    Ms Chow has had an increase when she was promoted to Managing Director and there have been other movements and additions as announced to the market. I don't believe there are any secrets around this subject and the Annual report will detail thus or it will not be signed by the Auditors.

    There are plenty of other downside risks that would have a greater impact to value than management remuneration.

    I am partly here due to the quality of the management team and am comfortable with their pay.

    It may be a good excercise to compare management remuneration against peers in Australia and especially in the US.

    Last edited by DrillDown2014: 01/09/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.